1. Home
  2. NEPH vs BNR Comparison

NEPH vs BNR Comparison

Compare NEPH & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NEPH
  • BNR
  • Stock Information
  • Founded
  • NEPH 1997
  • BNR 2014
  • Country
  • NEPH United States
  • BNR China
  • Employees
  • NEPH N/A
  • BNR N/A
  • Industry
  • NEPH Medical/Dental Instruments
  • BNR Medical Specialities
  • Sector
  • NEPH Health Care
  • BNR Health Care
  • Exchange
  • NEPH Nasdaq
  • BNR Nasdaq
  • Market Cap
  • NEPH 36.1M
  • BNR 29.1M
  • IPO Year
  • NEPH 2004
  • BNR 2020
  • Fundamental
  • Price
  • NEPH $4.03
  • BNR $3.31
  • Analyst Decision
  • NEPH Buy
  • BNR
  • Analyst Count
  • NEPH 1
  • BNR 0
  • Target Price
  • NEPH $5.00
  • BNR N/A
  • AVG Volume (30 Days)
  • NEPH 67.9K
  • BNR 37.2K
  • Earning Date
  • NEPH 08-07-2025
  • BNR 08-21-2025
  • Dividend Yield
  • NEPH N/A
  • BNR N/A
  • EPS Growth
  • NEPH N/A
  • BNR N/A
  • EPS
  • NEPH 0.08
  • BNR N/A
  • Revenue
  • NEPH $15,517,000.00
  • BNR $72,112,038.00
  • Revenue This Year
  • NEPH $17.06
  • BNR $136.32
  • Revenue Next Year
  • NEPH $12.20
  • BNR N/A
  • P/E Ratio
  • NEPH $53.08
  • BNR N/A
  • Revenue Growth
  • NEPH 10.34
  • BNR 0.53
  • 52 Week Low
  • NEPH $1.36
  • BNR $2.18
  • 52 Week High
  • NEPH $5.00
  • BNR $7.90
  • Technical
  • Relative Strength Index (RSI)
  • NEPH 56.63
  • BNR 53.05
  • Support Level
  • NEPH $3.83
  • BNR $3.06
  • Resistance Level
  • NEPH $4.39
  • BNR $3.50
  • Average True Range (ATR)
  • NEPH 0.47
  • BNR 0.29
  • MACD
  • NEPH -0.07
  • BNR -0.03
  • Stochastic Oscillator
  • NEPH 43.27
  • BNR 33.01

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.

Share on Social Networks: